Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions.
about
The Casitas B lineage lymphoma (Cbl) mutant G306E enhances osteogenic differentiation in human mesenchymal stromal cells in part by decreased Cbl-mediated platelet-derived growth factor receptor alpha and fibroblast growth factor receptor 2 ubiquitiFate decision of mesenchymal stem cells: adipocytes or osteoblasts?Bioprocessing strategies for the large-scale production of human mesenchymal stem cells: a reviewBone regeneration and stem cellsHuman Bone Marrow Mesenchymal Stem/Stromal Cells Preserve Their Immunomodulatory and Chemotactic Properties When Expanded in a Human Plasma Derived Xeno-Free Medium.Angiogenic factor-enriched platelet-rich plasma enhances in vivo bone formation around alloplastic graft material.The mesenchymal stem cell marker CD248 (endosialin) is a negative regulator of bone formation in mice.Cell population kinetics of collagen scaffolds in ex vivo oral wound repair.Platelet-rich plasma (PRP): methodological aspects and clinical applications.Platelet-rich plasma promotes the proliferation of human muscle derived progenitor cells and maintains their stemness.Individual variation in growth factor concentrations in platelet-rich plasma and its influence on human mesenchymal stem cellsAutologous platelet-rich plasma: a biological supplement to enhance adipose-derived mesenchymal stem cell expansion.Platelet-Derived Growth Factor BB Enhances Osteogenesis of Adipose-Derived But Not Bone Marrow-Derived Mesenchymal Stromal/Stem CellsRelease kinetics and mitogenic capacity of collagen barrier membranes supplemented with secretome of activated platelets - the in vitro response of fibroblasts of the periodontal ligament and the gingiva.Platelet-derived growth factor (PDGF)-AA/AB in human serum are potential indicators of the proliferative capacity of human synovial mesenchymal stem cellsCytokine-release kinetics of platelet-rich plasma according to various activation protocols.Platelet-derived growth factor and spatiotemporal cues induce development of vascularized bone tissue by adipose-derived stem cellsDual delivery of rhPDGF-BB and bone marrow mesenchymal stromal cells expressing the BMP2 gene enhance bone formation in a critical-sized defect model.Investigating the role of PDGF as a potential drug therapy in bone formation and fracture healing.State of the art and future perspectives of articular cartilage regeneration: a focus on adipose-derived stem cells and platelet-derived products.Ex vivo expansion of human mesenchymal stem cells in defined serum-free media.Platelet lysate as replacement for fetal bovine serum in mesenchymal stromal cell cultures.The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts.Rebuilding the Damaged Heart: Mesenchymal Stem Cells, Cell-Based Therapy, and Engineered Heart Tissue.Difference in release kinetics of unwashed and washed platelet-released supernatants from bone substitute materials: the impact of platelet preparation modalities.Human multipotent mesenchymal stem cells improve healing after collagenase tendon injury in the rat.Biological activity of a standardized freeze-dried platelet derivative to be used as cell culture medium supplement.Platelets increase while serum reduces the differentiation and activity of osteoclasts in vitro.A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice.Mesenchymal stem cells for regenerative therapy: optimization of cell preparation protocolsAcidic preparations of lysed platelets upregulate proliferative pathways in osteoblast-like cells as demonstrated by genome-wide microarray analysis.In vitro model to study chondrogenic differentiation in tendinopathy.Variation of pH in lysed platelet concentrates influence proliferation and alkaline phosphatase activity in human osteoblast-like cells.Human mesenchymal stem cells maintain their phenotype, multipotentiality, and genetic stability when cultured using a defined xeno-free human plasma fraction.Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-beta.Osteogenic differentiation induced by bone morphogenetic proteins can be suppressed by platelet-released supernatant in vitro.Platelet-rich concentrate in serum free medium enhances osteogenic differentiation of bone marrow-derived human mesenchymal stromal cells.Optimization of human mesenchymal stem cell manufacturing: the effects of animal/xeno-free media.Evaluation of effectiveness of concentrated growth factor on osseointegration.The basic science of peri-implant bone healing.
P2860
Q24303919-9F1FACBA-8645-4FFE-B808-51C70FA5EF36Q26766574-04C2FD6D-311B-478E-8930-47270349139BQ26776414-4F02869C-1A11-41B1-B6F2-4D0B8EF25E6FQ28659195-3CB2319C-7559-42D1-B95F-3CFBDD2446DAQ30853758-208A0D9A-6199-470E-9C3B-3F24E50AF8EAQ33774257-0264CB0D-77EE-4B80-9C2B-A1DE02C849A2Q34403310-E77E2158-4336-4B3A-A680-CBDCDD2D78AFQ34513810-3604A2BC-E996-469A-AB65-0827DF47EE01Q34659599-13701911-8881-4AFE-A9A9-19E54F648DDFQ34769510-2839B887-0AF1-4A69-B289-349EABC6A862Q35085531-18B1D2A7-24A3-4A11-A140-A475D02147F9Q35137316-30DF884D-7C51-4A00-B71C-52AD59A77C71Q35995598-9A8E8CC2-F429-4EBC-8B65-31B245B49B68Q36317597-56C27862-8CB9-4C8A-A82D-5EF2090A67D3Q36361591-26A41F69-179F-4EBB-8181-0E9972B8B39BQ36857015-6AA5FA1F-3B6F-423E-9172-33A8FC2B19F2Q37052102-018D91C1-8B3D-4896-BB17-6D76B8E712EBQ37253278-B1F03838-F1E2-4D07-AB57-F7C78AB76D62Q37595534-FEDB1A06-8173-40D5-831B-D9AA2F8A6AEDQ37853964-5DE40D3C-C3C5-4A4E-A54C-4F2DE895805EQ38014437-1644E88D-2E30-482F-ACD8-8B4D31B05144Q38165928-443CDB48-654E-49BA-96AA-B99543EAEE3CQ38314537-EE07FDA5-9B57-488F-8868-32C8C4532929Q38874116-2EFA420F-2D29-4428-A79B-CB005E8F23D2Q38928158-FDB4A2A0-CF64-4CC4-AE7F-E0CC63BD9DD2Q38994028-2F2BE614-2D69-49CB-8EE3-CD21D712EA17Q39120525-75EA08F0-7386-49B9-BE89-60E27438529BQ39147984-985E5767-5256-4019-8B05-3313612D5272Q39216286-056551FC-129B-419D-ACED-7C3B8F10B1C9Q39253499-63B54C7E-885E-4ADB-BD68-E2B6AA605662Q39510354-A986A33C-9243-4566-BBA5-B6889E3324FDQ39995829-A38B3DA4-6AF1-4F73-8D16-FF282DECB722Q40157980-BD4A7560-697C-40FD-95AD-F1A528CEDFD1Q40224864-7DAFCF18-1E48-4B7E-8990-A65FD3EA27B6Q40289353-D7DF7CBB-4E53-4B31-B8EB-632F77498534Q40296735-0C8928A6-1888-400A-8FCD-6CBA5CA2E8F2Q41062876-78BBA029-4084-4259-A07C-8410096433D3Q41881764-70C85129-9BE9-48AF-A30B-8EB71206BEB8Q42318576-97E63ED6-022C-4ABF-9BB7-902FAD76B236Q42662167-ACF7E588-5EBC-4A7F-8F43-36F41FD2E55A
P2860
Platelet-released supernatants increase migration and proliferation, and decrease osteogenic differentiation of bone marrow-derived mesenchymal progenitor cells under in vitro conditions.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Platelet-released supernatants ...... lls under in vitro conditions.
@en
Platelet-released supernatants ...... lls under in vitro conditions.
@nl
type
label
Platelet-released supernatants ...... lls under in vitro conditions.
@en
Platelet-released supernatants ...... lls under in vitro conditions.
@nl
prefLabel
Platelet-released supernatants ...... lls under in vitro conditions.
@en
Platelet-released supernatants ...... lls under in vitro conditions.
@nl
P2093
P2860
P50
P1433
P1476
Platelet-released supernatants ...... ells under in vitro conditions
@en
P2093
Barbara Kandler
Gabor Fuerst
Georg Watzek
Michael B Fischer
P2860
P356
10.1080/09537100310001643999
P577
2004-02-01T00:00:00Z